Peroxin 11α inhibitors are chemical compounds designed to target and inhibit the function of Peroxin 11α (Pex11α), a protein that plays a key role in the biogenesis and division of peroxisomes. Peroxisomes are essential organelles responsible for a variety of metabolic processes, including the breakdown of fatty acids and the detoxification of reactive oxygen species. Pex11α is involved in the elongation and division of peroxisomes, contributing to their proper distribution and maintenance within cells. By facilitating peroxisomal membrane remodeling, Pex11α ensures that peroxisomes can proliferate in response to cellular demands. Inhibitors of Pex11α disrupt this process, affecting peroxisomal dynamics and altering the organelle's ability to divide and proliferate.
At the molecular level, Peroxin 11α inhibitors may target specific domains of the protein that are critical for its role in peroxisomal membrane elongation and fission. Pex11α is known to interact with other proteins in the peroxisomal division machinery, such as dynamin-like proteins that mediate membrane scission. By blocking these interactions or interfering with the function of Pex11α directly, inhibitors prevent the normal division of peroxisomes, leading to changes in peroxisome number, size, and distribution within the cell. In experimental settings, these inhibitors are valuable for studying peroxisome biology, providing insights into the molecular mechanisms that regulate organelle biogenesis, lipid metabolism, and cellular detoxification processes. Researchers use Peroxin 11α inhibitors to explore how disruptions in peroxisomal division affect cellular function, particularly in relation to peroxisomal maintenance and metabolic homeostasis.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Pioglitazone | 111025-46-8 | sc-202289 sc-202289A | 1 mg 5 mg | $55.00 $125.00 | 13 | |
A thiazolidinedione that activates PPARγ, influencing peroxisome proliferation and potentially affecting Pex11α-related pathways. | ||||||
Rosiglitazone | 122320-73-4 | sc-202795 sc-202795A sc-202795C sc-202795D sc-202795B | 25 mg 100 mg 500 mg 1 g 5 g | $120.00 $326.00 $634.00 $947.00 $1259.00 | 38 | |
Another thiazolidinedione acting on PPARγ, which can indirectly influence peroxisome biogenesis and Pex11α activity. | ||||||
Fenofibrate | 49562-28-9 | sc-204751 | 5 g | $41.00 | 9 | |
A fibrate drug that activates PPARα, leading to changes in lipid metabolism and peroxisome proliferation, potentially impacting Pex11α. | ||||||
Clofibrate | 637-07-0 | sc-200721 | 1 g | $33.00 | ||
An older fibrate drug affecting PPARα and hence possibly influencing peroxisome dynamics and Pex11α function. | ||||||
Gemfibrozil | 25812-30-0 | sc-204764 sc-204764A | 5 g 25 g | $66.00 $267.00 | 2 | |
Similar to other fibrates, it activates PPARα and may affect peroxisome proliferation and Pex11α activity. | ||||||
WY 14643 | 50892-23-4 | sc-203314 | 50 mg | $136.00 | 7 | |
A potent PPARα agonist used in research to study peroxisome proliferation, potentially affecting Pex11α. | ||||||
LTB4 (Leukotriene B4) | 71160-24-2 | sc-201043 | 50 µg | $374.00 | 4 | |
Involved in inflammatory processes, it might influence peroxisome function and indirectly affect Pex11α. | ||||||
Ciprofibrate | 52214-84-3 | sc-204689 sc-204689A | 25 mg 100 mg | $58.00 $172.00 | ||
A fibrate that activates PPARα, possibly influencing peroxisome dynamics and Pex11α activity. | ||||||
Bezafibrate | 41859-67-0 | sc-204650B sc-204650 sc-204650A sc-204650C | 500 mg 1 g 5 g 10 g | $31.00 $46.00 $122.00 $204.00 | 5 | |
A fibrate drug affecting multiple PPAR subtypes, potentially influencing Pex11α through peroxisome modulation. | ||||||
Lovastatin | 75330-75-5 | sc-200850 sc-200850A sc-200850B | 5 mg 25 mg 100 mg | $29.00 $90.00 $339.00 | 12 | |
While primarily a statin, it has been shown to affect peroxisome proliferation, possibly impacting Pex11α. | ||||||